GCC2 and non-small cell lung carcinoma: Our ROC curve analysis showed that GCC2 has excellent diagnostic potential with an AUC of 0.844 (95% CI: 0.706–0.934, p < 0.001) when comparing healthy individuals and early-stage NSCLC patients.